SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CTVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 1.164B
March 31, 2026 877.00M
December 31, 2025 860.00M
September 30, 2025 725.00M
June 30, 2025 1.156B
March 31, 2025 751.00M
December 31, 2024 735.00M
September 30, 2024 671.00M
June 30, 2024 1.054B
March 31, 2024 736.00M
December 31, 2023 735.00M
September 30, 2023 670.00M
June 30, 2023 1.045B
March 31, 2023 726.00M
December 31, 2022 764.00M
September 30, 2022 657.00M
June 30, 2022 1.017B
March 31, 2022 735.00M
Date Value
December 31, 2021 806.00M
September 30, 2021 672.00M
June 30, 2021 998.00M
March 31, 2021 733.00M
December 31, 2020 724.00M
September 30, 2020 597.00M
June 30, 2020 965.00M
March 31, 2020 757.00M
December 31, 2019 747.00M
September 30, 2019 646.00M
June 30, 2019 937.00M
March 31, 2019 735.00M
December 31, 2018 889.00M
September 30, 2018 823.00M
June 30, 2018 1.182B
March 31, 2018 959.00M
December 31, 2017 865.00M
September 30, 2017 1.052B

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
FMC Corp. 179.10M
Scotts Miracle-Gro Co. 145.60M
The Chemours Co. 469.00M
CF Industries Holdings, Inc. 89.00M
Albemarle Corp. 126.35M